As per a regulatory filing, pharma company Dr Reddy's has informed that its subsidiary Dr Reddy's Research and Development, has signed an asset purchase agreement for its facility in the Netherlands.
As part of the pact that includes transfer of employees, Dr Reddy's will also pay more than $12 million to the purchaser for site-related expenses.
(If you have a story in and around Mumbai, you have our ears, be a citizen journalist and send us your story here. )
(To receive our E-paper on WhatsApp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)
